After Moderna contamination mess, Takeda strikes deal with Japan to supply Novavax COVID-19 vaccinesnews2021-09-07T13:53:26+00:00September 7th, 2021|Fierce Pharma|
Digital venture shines light on the pharma prescribing power of nurse practitioners and physician assistantsnews2021-09-07T12:44:36+00:00September 7th, 2021|Fierce Pharma|
Sunovion cashes in sublingual Parkinson’s drug, selling EU rights to Bialnews2021-09-07T10:00:40+00:00September 7th, 2021|Fierce Pharma|
Teva’s pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drugnews2021-09-07T09:56:15+00:00September 7th, 2021|Fierce Pharma|
Crippled by opioid-crisis litigation, Mallinckrodt settlement brings company closer to reorganizationnews2021-09-03T15:33:26+00:00September 3rd, 2021|Fierce Pharma|
AstraZeneca strikes COVID-19 vaccine delivery deal with Europe, ending high-profile legal battlenews2021-09-03T15:17:50+00:00September 3rd, 2021|Fierce Pharma|
CDC, FDA chiefs push back on White House COVID-19 booster plan: NYTnews2021-09-03T15:14:39+00:00September 3rd, 2021|Fierce Pharma|
Meet Neffy, the friendly epinephrine nasal spray from ARS Pharma awaiting FDA approvalnews2021-09-03T14:34:53+00:00September 3rd, 2021|Fierce Pharma|
With approval for China’s 2nd CAR-T therapy, Juno, WuXi joint venture goes up against Gilead and Fosun’s Yescartanews2021-09-03T14:00:34+00:00September 3rd, 2021|Fierce Pharma|
Lilly’s COVID-19 antibody combo cleared for nationwide use as feds say it can tackle the dominant delta variantnews2021-09-03T13:43:28+00:00September 3rd, 2021|Fierce Pharma|
